News | August 07, 2024
Gland Pharma posts 16% revenue growth in Q1 FY25
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
The approved product has an estimated market size of US$ 268 million for the twelve months ending June 2024, according to IQVIA
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
The inspections concluded with no Form 483 observations or significant critical findings
The pooled prevalence of GERD in the Indian population is 15.6 %
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
The company is planning to expand its plant capacity in in Vapi
Subscribe To Our Newsletter & Stay Updated
